Sign Up Today and Learn More About Click Therapeutics Stock
Invest in or calculate the value of your shares in Click Therapeutics or other pre-IPO companies through EquityZen's platform.
Click Therapeutics Stock (CLTH)
Digital Therapeutics Applications
About Click Therapeutics Stock
Founded
2012
Headquarters
New York, NY, US
Total Funding
37.1M
Industries
Software, Artificial Intelligence, Data and Analytics
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
Click Therapeutics Press Mentions
Stay in the know about the latest news on Click Therapeutics
Wearables’ future in healthcare likely to hinge on actionable insights
medicaldevice-network • Feb 06, 2026
Find the cause: Ultrahuman's latest feature aims to help users with migraines
androidcentral • Jan 18, 2026
Ultrahuman and Click Therapeutics partner on biomarker-driven migraine tool
longevity • Jan 16, 2026
This smart ring feature wants to help uncover your migraine triggers
androidauthority • Jan 16, 2026
Ultrahuman and Click Therapeutics partner to launch the world’s first biomarker-driven migraine management tool based on FDA-authorized technology
globenewswire • Jan 16, 2026
Investors in Click Therapeutics
Discover investors in Click Therapeutics stock and explore their portfolio companies
Click Therapeutics Management
Leadership team at Click Therapeutics
Chief Executive Officer
David Benshoof Klein
Chief Technology Officer
Christopher Jordan
Join now and verify your accreditation status to gain access to:
- Click Therapeutics Current Valuation
- Click Therapeutics Stock Price
- Click Therapeutics Management
- Available deals in Click Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Click Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Click Therapeutics Revenue and Financials
- Click Therapeutics Highlights
- Click Therapeutics Business Model
- Click Therapeutics Risk Factors
- Click Therapeutics Research Report from SACRA Research
Trading Click Therapeutics Stock
How to invest in Click Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Click Therapeutics through EquityZen funds. These investments are made available by existing Click Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Click Therapeutics stock?
Shareholders can sell their Click Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
